Yafang Huang

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Systematic Review

Interstitial Lung Disease

Drug Administration

Top Venues

Expert review of clinical pharmacology

Cancer medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yafang Huang, Jinqiu Yuan
Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs. Expert review of clinical pharmacology 17 (5-6) (2024)
Yafang Huang, Jinqiu Yuan
Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs. Expert review of clinical pharmacology (2024)
Yafang Huang, Jinqiu Yuan
Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs. Expert review of clinical pharmacology 17 (5-6) (2024)
Yafang Huang, Jinqiu Yuan
Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs. Expert review of clinical pharmacology (2024)
Yafang Huang, Weiyi Xiong, Li Ma, Hao Wu
A cross-sectional study of the FDA approved indications and supporting pivotal trials of small-molecular kinase inhibitors in cancer therapies with the biomarker of cancer driver gene. International journal of cancer 151 (12) (2022)
Yafang Huang, Haiyu Fan, Ning Li, Juan Du
Risk of immune-related pneumonitis for PD1/PD-L1 inhibitors: Systematic review and network meta-analysis. Cancer medicine 8 (5) (2019)